96
Participants
Start Date
June 16, 2025
Primary Completion Date
May 11, 2026
Study Completion Date
May 11, 2026
Oxandrolone
Absorbable oxandrolone implant (subdermal insertion) Men: 400 mg oxandrolone (two 200 mg oxandrolone implants each) Women: 200 mg oxandrolone (one 200 mg oxandrolone implant)
Placebo
Absorbable placebo implant (excipients; subdermal insertion) Men: 400 mg placebo (two 200 mg placebo implants each) Women: 200 mg placebo (one 200 mg placebo implant)
Science Valley Research Institute, São Paulo, Sao Paulo, São Paulo
Stin Pharma
UNKNOWN
Science Valley Research Institute
OTHER